Novavax Common Stock from 2010 to 2024
| 0A3S Stock | 11.90 3.06 34.62% |
Common Stock | First Reported 2010-12-31 | Previous Quarter 781.2 K | Current Value 813.2 K | Quarterly Volatility 1.4 M |
Check Novavax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novavax's main balance sheet or income statement drivers, such as Interest Income of 13.2 M, Interest Expense of 0.0 or Selling General Administrative of 175.4 M, as well as many indicators such as . Novavax financial statements analysis is a perfect complement when working with Novavax Valuation or Volatility modules.
Novavax | Common Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.